Rozella buys CE 60.73: Medtronic Reports Modest Revenue Growth But Litigation Hurts Profits
Medtronicâs (NYSE: MDT) recently reported fourth quarter fiscal 2014 results ... The medical device maker also received CE Mark for its Evera MRI SureScan ICD in the later half of the fiscal fourth quarter and should see meaningful sales in FY15. ...
27 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home